Decreased expression of p27 is associated with malignant transformation and extrathyroidal extension in papillary thyroid carcinoma
- 180 Downloads
Cell cycle regulatory proteins including p16, p27, and p53 are well studied in various cancers. However, their single or concurrent roles related with the clinicopathological parameters are not clearly recognized. We analyzed the expression of p16, p27, and p53 cell cycle regulatory proteins in papillary thyroid carcinoma (PTC). To determine the prognostic significance of cell cycle regulatory proteins, 107 PTCs were examined. We analyzed the individual expression of p16, p27, and p53 and their concurrent expressions, with the relationship to various clinicopathological parameters including differentiation from benign lesions. High expression of p16 and p53 and low expression of p27 were related with the distinguishing of PTC from benign lesions. In addition, normal thyroidal tissue showed higher p27 expression than nodular hyperplasia. In relation to extrathyroidal extension (ETE), the low expression of p27 was related with the presence of ETE. The low expression of p27 and high expression of p16 and p53 may affect the development of PTC. In addition, low p27 expression is related with the existence of ETE.
KeywordsPapillary thyroid carcinoma p16 p27 p53 Extrathyroidal extension
Compliance with ethical standards
For this type of study, formal consent is not required.
Conflicts of interest
- 1.Hundahl SA, Cady B, Cunningham MP, Mazzaferri E, McKee RF, Rosai J, et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation Study. Cancer. 2000;89(1):202–17.CrossRefPubMedGoogle Scholar
- 3.Ito Y, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, et al. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J Surg. 2007;31(11):2085–91. doi: 10.1007/s00268-007-9224-y.CrossRefPubMedGoogle Scholar
- 4.Mercante G, Frasoldati A, Pedroni C, Formisano D, Renna L, Piana S, et al. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid: Off J Am Thyroid Assoc. 2009;19(7):707–16. doi: 10.1089/thy.2008.0270.CrossRefGoogle Scholar
- 10.Knosel T, Altendorf-Hofmann A, Lindner L, Issels R, Hermeking H, Schuebbe G, et al. Loss of p16(INK4a) is associated with reduced patient survival in soft tissue tumours, and indicates a senescence barrier. J Clin Pathol. 2014;67(7):592–8. doi: 10.1136/jclinpath-2013-202106.CrossRefPubMedGoogle Scholar
- 12.Zafon C, Obiols G, Castellvi J, Ramon y Cajal S, Baena JA, Mesa J. Expression of p21cip1, p27kip1, and p16INK4a cyclin-dependent kinase inhibitors in papillary thyroid carcinoma: Correlation with clinicopathological factors. Endocr Pathol. 2008;19(3):184–9. doi: 10.1007/s12022-008-9037-z.CrossRefPubMedGoogle Scholar
- 32.Bai L, Zhu WG, P53: Structure, function and therapeutic applications. 2006.Google Scholar